
Vertex Pharmaceuticals NASDAQ: VRTX outlined a broadening commercial and clinical strategy at the Cantor Global Healthcare Conference, highlighting its recent Crinetics acquisition, planned renal prod
Vertex, Inc. (VERX) Presents at Goldman Sachs Communacopia + Technology Conference 2026 Transcript
Vertex, Inc. (VERX) Q2 2026 Earnings Call Transcript

Vertex Software remains deeply undervalued despite a strong Q2 beat and raised guidance, trading near multi-year lows. VERX's specialized tax automation niche is resilient to AI disruption, with robus
Vertex NASDAQ: VERX reported second-quarter revenue at the high end of its guidance range and raised its full-year adjusted EBITDA outlook, as the tax technology company cited cost discipline, stable